You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Drug

Published Date: 27 Apr 2026

Revision Summary:
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Apr 2026
Regimen
Published Date: 24 Apr 2026
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Intent section

Updated
Apr 2026
Regimen
Published Date: 23 Apr 2026
Cancer Type:
Gastrointestinal, 
Pancreas
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supportive Care, Adverse Effects, Drug Administration/Special Precautions, and Monitoring sections

Updated
Apr 2026
Drug

Published Date: 23 Apr 2026

Revision Summary:
Drug Monograph: Updated Mechanism of Action, Adverse Effects, Dosage with Toxicity, Administration, Special Precautions, Interactions, and Monitoring sections
Patient Info Sheet EN: Updated/revised information sheet
Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Hematologic, 
Myelofibrosis
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: new ST-QBP regimen; Updated regimen code

Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Revision Summary:

Regimen Monograph: new ST-QBP regimen; Updated regimen code for pembrolizumab monotherapy phase

Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dose modification, Adverse effects, Pregnancy and breastfeeding and Monitoring sections

Updated
Apr 2026
Regimen
Published Date: 20 Apr 2026
Cancer Type:
Endocrine, 
Thyroid
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dose modifications; Adverse effects, Pregnancy and breastfeeding and Monitoring sections

Updated
Apr 2026
Drug

Published Date: 20 Apr 2026

Revision Summary:
Drug Monograph: Modified Indications, Adverse effects, Dosing, Pregnancy/lactation, Interactions, and Monitoring sections
Patient Info Sheet EN: Updated/Revised information sheet
Updated
Apr 2026
Drug

Published Date: 13 Apr 2026

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, and Monitoring sections
Updated
Apr 2026

Pages